These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 12841847)
1. The POU homeodomain protein OCT3 as a potential transcriptional activator for fibroblast growth factor-4 (FGF-4) in human breast cancer cells. Wang P; Branch DR; Bali M; Schultz GA; Goss PE; Jin T Biochem J; 2003 Oct; 375(Pt 1):199-205. PubMed ID: 12841847 [TBL] [Abstract][Full Text] [Related]
2. Distal enhancer of the mouse FGF-4 gene and its human counterpart exhibit differential activity: critical role of a GT box. Boer B; Luster TA; Bernadt C; Rizzino A Mol Reprod Dev; 2005 Jul; 71(3):263-74. PubMed ID: 15803454 [TBL] [Abstract][Full Text] [Related]
3. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta. Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924 [TBL] [Abstract][Full Text] [Related]
4. k-FGF protoncogene expression is associated with murine testicular teratogenesis, but is not involved during mouse testicular development. de Anta JM; Monzó M; Peris B; Ruano D Histol Histopathol; 1997 Jan; 12(1):33-41. PubMed ID: 9046041 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of Oct-4 activity by Ewing's sarcoma protein. Lee J; Rhee BK; Bae GY; Han YM; Kim J Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470 [TBL] [Abstract][Full Text] [Related]
6. Regulation of FGF-4 enhancer activity by transcription factor NF-Y. Bryans M; Lucas JM; Knobloch TJ; Wilkie NM; Lang JC Biochem Biophys Res Commun; 1995 Jun; 211(2):519-27. PubMed ID: 7794264 [TBL] [Abstract][Full Text] [Related]
7. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Ethier SP; Kokeny KE; Ridings JW; Dilts CA Cancer Res; 1996 Feb; 56(4):899-907. PubMed ID: 8631031 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the murine k-fgf gene. Rizzino A; Rosfjord E Mol Reprod Dev; 1994 Sep; 39(1):106-11. PubMed ID: 7999355 [TBL] [Abstract][Full Text] [Related]
9. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas. Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278 [TBL] [Abstract][Full Text] [Related]
10. Retinoic acid-mediated down-regulation of Oct3/4 coincides with the loss of promoter occupancy in vivo. Minucci S; Botquin V; Yeom YI; Dey A; Sylvester I; Zand DJ; Ohbo K; Ozato K; Scholer HR EMBO J; 1996 Feb; 15(4):888-99. PubMed ID: 8631309 [TBL] [Abstract][Full Text] [Related]
11. The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression. Eisen T; Easty DJ; Bennett DC; Goding CR Oncogene; 1995 Nov; 11(10):2157-64. PubMed ID: 7478537 [TBL] [Abstract][Full Text] [Related]
12. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1. Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233 [TBL] [Abstract][Full Text] [Related]
13. Effect of all-trans-retinoic acid on c-fms proto-oncogene [colony-stimulating factor 1 (CSF-1) receptor] expression and CSF-1-induced invasion and anchorage-independent growth of human breast carcinoma cells. Sapi E; Flick MB; Tartaro K; Kim S; Rakhlin Y; Rodov S; Kacinski BM Cancer Res; 1999 Nov; 59(21):5578-85. PubMed ID: 10554038 [TBL] [Abstract][Full Text] [Related]
14. From adult stem cells to cancer stem cells: Oct-4 Gene, cell-cell communication, and hormones during tumor promotion. Trosko JE Ann N Y Acad Sci; 2006 Nov; 1089():36-58. PubMed ID: 17261754 [TBL] [Abstract][Full Text] [Related]
15. The specific activation of gadd45 following UVB radiation requires the POU family gene product N-oct3 in human melanoma cells. Lefort K; Rouault JP; Tondereau L; Magaud JP; Doré JF Oncogene; 2001 Nov; 20(50):7375-85. PubMed ID: 11704867 [TBL] [Abstract][Full Text] [Related]
16. NF-Y binds to the CCAAT box motif of the FGF-4 gene and promotes FGF-4 expression in embryonal carcinoma cells. Lamb KA; Johnson LR; Rizzino A Mol Reprod Dev; 1997 Nov; 48(3):301-9. PubMed ID: 9322240 [TBL] [Abstract][Full Text] [Related]
17. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells. Chai Y; Chipitsyna G; Cui J; Liao B; Liu S; Aysola K; Yezdani M; Reddy ES; Rao VN Oncogene; 2001 Mar; 20(11):1357-67. PubMed ID: 11313879 [TBL] [Abstract][Full Text] [Related]
18. Enhanced invasion and tumor growth of fibroblast growth factor 8b-overexpressing MCF-7 human breast cancer cells. Ruohola JK; Viitanen TP; Valve EM; Seppänen JA; Loponen NT; Keskitalo JJ; Lakkakorpi PT; Härkönen PL Cancer Res; 2001 May; 61(10):4229-37. PubMed ID: 11358849 [TBL] [Abstract][Full Text] [Related]
19. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Han S; Inoue H; Flowers LC; Sidell N Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539 [TBL] [Abstract][Full Text] [Related]
20. Differential activity of the FGF-4 enhancer in F9 and P19 embryonal carcinoma cells. Boer B; Bernadt CT; Desler M; Wilder PJ; Kopp JL; Rizzino A J Cell Physiol; 2006 Jul; 208(1):97-108. PubMed ID: 16523502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]